Abstract
Mortality rate, prognosis, and treatment outcome of cancer patients depend strongly on the detection of malignancy at an early stage and efficient monitoring of the disease. Multimodality diagnostic approaches are now widely applied for tumor detection, staging, and follow-up. However, the introduction of whole-body imaging modalities into clinical practice has substantially expanded diagnostic options. PET-CT has increased diagnostic accuracy by providing “anatometabolic” information by fusing tumor glucose-uptake measures from the PET examination and accurate delineation of anatomical structures given by spiral CT. Since PET-CT is associated with high doses of ionizing radiation, it is used in mainly tumor staging and screening within the scope of tertiary prevention. Here promising results have been reported for various tumor entities. MRI provides excellent tissue contrast, detailed morphological information and lack of ionizing radiation. MRI has been employed for the assessment of focal pathologies in specific anatomical regions. Whole-body MRI scanners using multiple receiver channels with parallel acquisition techniques now allow tumor screening from head to toe within substantially shorter examination times and without compromises in image resolution. We report our experience with these two novel techniques and discuss their benefits and drawbacks in terms of systemic tumor screening.
Similar content being viewed by others
References
World Health Organization (2004) WHO health report 2004: statistical annex. http://www.who.int. World Health Organization, Geneva, Switzerland
Bayes T (1763) An essay towards solving a problem in the doctrine of chances. Philos Trans R Soc Lond 53:370–418
Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R et al (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med 41:1369–13679
Pelosi E, Messa C, Sironi S, Picchio M, Landoni C, Bettinardi V et al (2004) Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study. Eur J Nucl Med Mol Imaging 31:932–939
Lardinois D, Weder W, Hany TF, Kamel EM, Korom S et al (2003) Staging of non-small-cell cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500–2507
Cohade C, Osman M, Leal J, Wahl RL (2003) Direct comparison of 18F-FDG-PET and PET-CT in patients with colorectal carcinoma. J Nucl Med 44:1797–1803
Wechalekar K, Sharma B, Cook G (2005) PET/CT in oncology-a major advance. Clin Radiol 60:1143–1155
Barkhausen J, Quick HH, Lauenstein T et al (2001) Whole-body MR imaging in 30 seconds with real-time true FISP and a continously rolling table platform: feasability study. Radiology 220:252–256
Pruessmann KP, Weiger M, Scheidegger MB et al (1999) SENSE: sensitivity encoding for fast MRI. Magn Reson Med 42:952–962
Griswold MA, Jakob PM, Heidemann RM et al (2002) Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 47:1202–1210
Roemer PB, Edelstein WA, Hayes CE, Souza SP, Mueller OM (1990) The NMR phased array. Magn Reson Med 16:192–225
Keupp J, Aldefeld B, Bornert P (2005) Continously moving table SENSE imaging. Magn Reson Med 53:217–220
Anonymous (2004) Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO). http://www3.cancer.gov/prevention/plco
Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. New Eng J Med 27:1784–1792
Nicholson FB, Barro JL, Bartram CI, Dehmeshki J, Halligan S, Taylor S, Kamm MA et al (2005) The role of CT colonography in colorectal cancer screening. Am J Gastroenterol 100:2315–2323
Diederich S, Wormanns D, Semik M, Thomas M, Lenzen, Roos N et al (2002) Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology:773–778
European Comission on Energy (2004) Europe. http://europa.eu.int/comm/erergy/nuclear/radioprotection/doc/legislation/9743_en.pdf; accessed November 22
Brix G, Lechel U, Glatting G, Ziegler SI, Münzing W, Müller SP, Beyer T (2005) Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. J Nucl Med 46:608–613
Goehde SC, Hunold P, Vogt FM, Ajaj W, Goyen M, Herborn CU et al (2005) Full-body cardiovascular and tumor MRI for early detection of disease: feasibility and initial experience in 298 subjects. Am J Roentgenol 184:598–611
Kramer H, Schoenberg SO, Nikolaou K, Huber A, Struwe A, Winnik E (2005) Cardiovascular screening with parallel imaging techniques and a whole-body imager. Radiology 236:300–310
Ajaj W, Pelster G, Treichel U, Vogt FM, Debatin JF, Ruehm SG (2003) Dark lumen magnetic resonance colonography: comparison with conventional colonoscopy fort he detection of colorectal pathology. Gut 52:1738–1743
American Joint Committee on Cancer (2002) AJCC cancer staging manual, 6th edn. Springer, Berlin Heidelberg New York
Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T et al (2004) Accuracy of whole-body dual-modality fluorine-18–2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 22:4357–4368
Semelka RC, Worawattanakul S, Kelekis NL et al (1997) Liver lesion detection, characterization, and effect on patient management: comparison of single phase spiral-CT and current MR techniques. J Magn Reson Imaging 7:1040–1047
Steinborn M, Heuck AF, Tiling R, Bruegel M, Gauger L, Reiser MF (1999) Whole body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 23:123–129
Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J et al (2003) Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290:3199–3206
Schmidt GP, Baur-Melnyk A, Herzog P, Schmid R, Tiling R, Reiser MF et al (2005) High-resolution whole-body MRI tumor staging with the use of parallel imaging versus dual modality PET-CT: experience on a 32-channel system. Invest Radiol 40:743–7531
Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T et al (2004) Accuracy of whole-body dual-modality fluorine-18–2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 22:4357–4368
Gutzeit A, Antoch G, Kühl H, Egelhof T, Fischer M, Hauth E et al (2005) Unknown primary tumours: detection with dual-modality PET-CT-initial experience. Radiology 234:227–234
Brennan DD, Gleeson T, Coate LE, Cronin C, Carney D, Eustace SJ (2005) A comparison of whole-body MRI and CT for the staging of lymphoma. Am J Roentgenol 185:711–716
Kellenberger CJ, Miller SF, Khan M, Gilday D, Weitzman S, Babyn PS (2004) Initial experience with FSE STIR-whole-body MR imaging for staging lymphoma in children. Eur Radiol 14:1829–1841
Pieterman RM, van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Kotere GH et al (2000) Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343:254–261
Takahara T, Imay Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M (2004) Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 22:275–282
Ohno Y, Hatabu H, Takenaka D, Higashino T, Watanabe H, Ohbayashi C et al (2004) Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. Radiology 231:872–879
Ghanem N, Uhl M, Brink I, Schäfer O, Kelly T, Moser E (2005) Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET-CT for the detection of metastases of bone. Eur J Radiol 55:41–55
Mentzel HJ, Kentouche K, Sauner D, Fleischmann C, Vogt S, Gottschild D (2004) Comparison of whole-body STIR-MRI and 99m-Tc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions. Eur Radiol 14:2297–2302
Schmidt GP, Schoenberg SO, Reiser MF, Baur-Melnyk A (2005) Whole-body MR imaging of bone marrow. Eur J Radiol 55:33–40
Daldrup-Link HE, Franzius C, Link TM et al (2001) Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 177:229–236
Schlemmer HP, Schäfer J, Pfannenberg C, Radny P, Korchidi S, Müller-Horvat C (2005) Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system: initial experiences. Invest Radiol 40:64–71
Cook GJ, Wegner E, Fogleman I (2004) Pitfalls and artefacts in 18 FDG-PET and PET-CT oncologic imaging. Semin Nucl Med 34:122–133
Goerres GW, Kamel E, Heidelberg TN, Schwitter MR, Burger C, von Schuthess GK (2002) Accuracy of image co-registration in the thorax: influence of respiration. Eur J Nucl Med Mol Imaging 29:351–360
Antoch G, Freudenberg LS, Stattaus J, Jentzen W, Debatin JF et al (2002) Focal tracer uptake: a potential artefact in contrast-enhanced dual-modality PET-CT scans. J Nucl Med 43:1339–1342
Ichikawa T, Erturk S, Motosuqi U, Sano K, Ros P et al (2005) Virtual PET-MRI as a novel oncologic imaging of the body: principles, techniques and clinical applications. RSNA 2005, abstract 1330BP-e
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schmidt, G.P., Haug, A.R., Schoenberg, S.O. et al. Whole-body MRI and PET-CT in the management of cancer patients. Eur Radiol 16, 1216–1225 (2006). https://doi.org/10.1007/s00330-006-0183-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-006-0183-8